WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea · Delayed Price · Currency is KRW 8,860.00
+1,060.00 (13.59%)
At close: Jun 19, 2026
KOSDAQ:330350 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,292 | 4,967 | 4,785 | 7,959 | 2,479 | 4,264 |
Depreciation & Amortization | 4,172 | 4,084 | 3,778 | 2,844 | 1,948 | 1,501 |
Loss (Gain) From Sale of Assets | - | - | - | -9.04 | -10.78 | 385 |
Asset Writedown & Restructuring Costs | 1,819 | 1,819 | 205 | - | - | - |
Loss (Gain) From Sale of Investments | -309.07 | 348.82 | 133.97 | -1,515 | 352.72 | -979.32 |
Provision & Write-off of Bad Debts | -2.6 | -34.88 | -154.86 | 110.06 | 82.62 | 227.95 |
Other Operating Activities | -821.87 | 63.67 | 812.04 | 801.52 | 401.65 | 1,698 |
Change in Accounts Receivable | -2,484 | -3,417 | 3,847 | -8,072 | 717.7 | 1,545 |
Change in Inventory | -1,962 | -2,989 | -85.24 | -6,970 | -840.21 | -242.48 |
Change in Accounts Payable | 479.73 | 1,307 | -3,570 | 3,743 | 1,012 | -433.87 |
Change in Other Net Operating Assets | -470 | 631.5 | -120.8 | -129.6 | -763.09 | 56.29 |
Operating Cash Flow | 7,713 | 6,781 | 9,630 | -1,237 | 5,380 | 8,021 |
Operating Cash Flow Growth | -26.47% | -29.58% | - | - | -32.93% | 890.81% |
Capital Expenditures | -4,464 | -1,298 | -2,362 | -10,807 | -15,332 | -6,667 |
Sale of Property, Plant & Equipment | - | - | - | 9.05 | 11.82 | - |
Sale (Purchase) of Intangibles | -2,027 | -1,817 | -3,700 | -1,195 | -2,442 | -3,627 |
Investment in Securities | 758.56 | 1,059 | 1,123 | 14,588 | 9,846 | -5,257 |
Other Investing Activities | -27.87 | -37.87 | 369 | 56.8 | -30 | -6 |
Investing Cash Flow | -5,166 | -1,766 | -3,630 | 3,223 | -7,892 | -14,935 |
Short-Term Debt Issued | - | 16,030 | 21,987 | 15,470 | 18,649 | 11,917 |
Long-Term Debt Issued | - | - | - | 1,400 | 2,800 | 4,700 |
Total Debt Issued | 19,030 | 16,030 | 21,987 | 16,870 | 21,449 | 16,617 |
Short-Term Debt Repaid | - | -19,030 | -14,412 | -16,565 | -18,969 | -9,667 |
Long-Term Debt Repaid | - | -2,519 | -3,535 | -2,215 | -4,191 | -1,220 |
Total Debt Repaid | -16,547 | -21,549 | -17,946 | -18,779 | -23,159 | -10,887 |
Net Debt Issued (Repaid) | 2,483 | -5,519 | 4,041 | -1,909 | -1,710 | 5,730 |
Issuance of Common Stock | - | - | - | 84.55 | 37.54 | - |
Repurchase of Common Stock | - | - | - | - | - | -35.66 |
Dividends Paid | - | - | -1,319 | - | -632.94 | -422.04 |
Other Financing Activities | - | - | -0.81 | -0.02 | -0.67 | -18.25 |
Financing Cash Flow | 2,483 | -5,519 | 2,721 | -1,825 | -2,307 | 5,254 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.03 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 | - | -0 |
Net Cash Flow | 5,030 | -503.85 | 8,720 | 161.51 | -4,819 | -1,660 |
Free Cash Flow | 3,249 | 5,483 | 7,268 | -12,044 | -9,952 | 1,354 |
Free Cash Flow Growth | -62.20% | -24.56% | - | - | - | - |
Free Cash Flow Margin | 2.98% | 5.15% | 7.07% | -15.03% | -15.39% | 2.36% |
Free Cash Flow Per Share | 246.01 | 415.40 | 549.86 | -912.45 | -754.70 | 102.59 |
Cash Interest Paid | 649.85 | 834.74 | 785.94 | 726.81 | 632.38 | 326.61 |
Cash Income Tax Paid | - | 455.69 | 406.7 | 1,021 | 2,029 | 242.26 |
Levered Free Cash Flow | -4,156 | -31.76 | 1,901 | -13,576 | -10,942 | -3,011 |
Unlevered Free Cash Flow | -3,746 | 414.9 | 2,409 | -13,204 | -10,698 | -2,809 |
Change in Working Capital | -4,436 | -4,466 | 71.13 | -11,428 | 126.02 | 924.71 |